TR200100643T2 - Yüksek-çekimli antikorlar - Google Patents
Yüksek-çekimli antikorlarInfo
- Publication number
- TR200100643T2 TR200100643T2 TR2001/00643T TR200100643T TR200100643T2 TR 200100643 T2 TR200100643 T2 TR 200100643T2 TR 2001/00643 T TR2001/00643 T TR 2001/00643T TR 200100643 T TR200100643 T TR 200100643T TR 200100643 T2 TR200100643 T2 TR 200100643T2
- Authority
- TR
- Turkey
- Prior art keywords
- samples
- hour
- antibody
- draft
- incubating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6815—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Yüksek-çekimli monoklonal antikorlar tarif edilmektedir,ki burada çekim asagidaki sekilde belirlenebilir: (i) birinci ve ikinci antikor numunelerinin 37 C bir saat 7.2 pH'de standart bir egrinin lineer tepki bölümü içinde olmak sartiyla seçilen bir konsantrasyonda antijen-kapli mikrotitre plakasi gözeneklerinde kuluçkalanmasi; (ii) her iki numuneden baglanmamis antikorlarin uzaklastirilmasi; (iii) birinci numunenin 37 C'de 1 saat 7.2 pH'de PBS ile kuluçkalanmasi, ve pH'sinin pH 3 veya daha altina düsürülmesi ve 37 C'de bir saat kuluçkalanmasi; (iv) her iki numuneden baglanmamis antikorun uzaklastirilmasi; (v) her iki numunenin 37 C'de 1 saat anti-antikor alkalin-fosfataz eslenik ile kuluçkalanmasi; (vi) her iki numuneden baglanmamis eslenigin uzaklastirilmasi; ve (vii) numunelere PNPP maddesinin eklenmesi, 405nm'de numunelerin emme kapasitelerinin ölçülmesi, ve antijene baglanan antikor miktarinin belirlenmesi, ki burada ikinci numunede bagli olan miktar birinci numunedek(DEVAMI VAR)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9818915.2A GB9818915D0 (en) | 1998-08-28 | 1998-08-28 | Antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200100643T2 true TR200100643T2 (tr) | 2001-07-23 |
Family
ID=10838074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/00643T TR200100643T2 (tr) | 1998-08-28 | 1999-08-20 | Yüksek-çekimli antikorlar |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1107990A1 (tr) |
| JP (1) | JP2002525082A (tr) |
| KR (1) | KR20010089174A (tr) |
| CN (1) | CN1315966A (tr) |
| AU (1) | AU5435099A (tr) |
| BG (1) | BG105294A (tr) |
| BR (1) | BR9913303A (tr) |
| CA (1) | CA2340865A1 (tr) |
| EA (1) | EA200100287A1 (tr) |
| GB (1) | GB9818915D0 (tr) |
| HR (1) | HRP20010149A2 (tr) |
| HU (1) | HUP0103233A3 (tr) |
| ID (1) | ID28905A (tr) |
| IL (1) | IL141523A0 (tr) |
| MX (1) | MXPA01002248A (tr) |
| NO (1) | NO20011006D0 (tr) |
| PL (1) | PL346472A1 (tr) |
| TR (1) | TR200100643T2 (tr) |
| WO (1) | WO2000012556A1 (tr) |
| YU (1) | YU15401A (tr) |
| ZA (1) | ZA200101573B (tr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0031284D0 (en) * | 2000-12-21 | 2001-01-31 | Ks Biomedix Ltd | High affinity antibodies |
| GB0112844D0 (en) * | 2001-05-25 | 2001-07-18 | Psimei Pharmaceuticals Plc | Neutron capture therapy |
| AU2003256266A1 (en) * | 2002-06-12 | 2003-12-31 | Genencor International, Inc. | Methods and compositions for milieu-dependent binding of a targeted agent to a target |
| US20030232401A1 (en) * | 2002-06-12 | 2003-12-18 | Pugia Michael J. | Bacterial test method by glycated label binding |
| JP4982183B2 (ja) * | 2003-12-12 | 2012-07-25 | ジェネンコー・インターナショナル・インク | Ｃａｂ分子 |
| CN111848790B (zh) * | 2020-08-07 | 2022-02-22 | 上海交通大学 | 一种牛源抗金黄色葡萄球菌的单链抗体及其制备和应用 |
| CN112724255A (zh) * | 2021-01-28 | 2021-04-30 | 成都金昆生物科技有限公司 | 靶向癌胚抗原的小分子抗体 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5081235A (en) * | 1989-07-26 | 1992-01-14 | City Of Hope | Chimeric anti-cea antibody |
| GB9014932D0 (en) * | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
-
1998
- 1998-08-28 GB GBGB9818915.2A patent/GB9818915D0/en not_active Ceased
-
1999
- 1999-08-20 MX MXPA01002248A patent/MXPA01002248A/es unknown
- 1999-08-20 HU HU0103233A patent/HUP0103233A3/hu unknown
- 1999-08-20 HR HR20010149A patent/HRP20010149A2/hr not_active Application Discontinuation
- 1999-08-20 WO PCT/GB1999/002729 patent/WO2000012556A1/en not_active Ceased
- 1999-08-20 YU YU15401A patent/YU15401A/sh unknown
- 1999-08-20 EP EP99940355A patent/EP1107990A1/en not_active Withdrawn
- 1999-08-20 ID IDW20010714A patent/ID28905A/id unknown
- 1999-08-20 KR KR1020017002434A patent/KR20010089174A/ko not_active Withdrawn
- 1999-08-20 CN CN99810367A patent/CN1315966A/zh active Pending
- 1999-08-20 TR TR2001/00643T patent/TR200100643T2/tr unknown
- 1999-08-20 CA CA002340865A patent/CA2340865A1/en not_active Abandoned
- 1999-08-20 AU AU54350/99A patent/AU5435099A/en not_active Abandoned
- 1999-08-20 EA EA200100287A patent/EA200100287A1/ru unknown
- 1999-08-20 IL IL14152399A patent/IL141523A0/xx unknown
- 1999-08-20 BR BR9913303-2A patent/BR9913303A/pt not_active IP Right Cessation
- 1999-08-20 PL PL99346472A patent/PL346472A1/xx not_active Application Discontinuation
- 1999-08-20 JP JP2000571062A patent/JP2002525082A/ja active Pending
-
2001
- 2001-02-26 BG BG105294A patent/BG105294A/bg unknown
- 2001-02-26 ZA ZA200101573A patent/ZA200101573B/en unknown
- 2001-02-27 NO NO20011006A patent/NO20011006D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1107990A1 (en) | 2001-06-20 |
| KR20010089174A (ko) | 2001-09-29 |
| HUP0103233A2 (hu) | 2001-12-28 |
| CA2340865A1 (en) | 2000-03-09 |
| WO2000012556A1 (en) | 2000-03-09 |
| YU15401A (sh) | 2003-07-07 |
| ID28905A (id) | 2001-07-12 |
| HUP0103233A3 (en) | 2003-10-28 |
| NO20011006L (no) | 2001-02-27 |
| HRP20010149A2 (en) | 2002-02-28 |
| BG105294A (bg) | 2001-12-29 |
| PL346472A1 (en) | 2002-02-11 |
| IL141523A0 (en) | 2002-03-10 |
| BR9913303A (pt) | 2001-10-09 |
| NO20011006D0 (no) | 2001-02-27 |
| GB9818915D0 (en) | 1998-10-21 |
| AU5435099A (en) | 2000-03-21 |
| JP2002525082A (ja) | 2002-08-13 |
| ZA200101573B (en) | 2002-02-26 |
| EA200100287A1 (ru) | 2001-08-27 |
| CN1315966A (zh) | 2001-10-03 |
| MXPA01002248A (es) | 2002-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yolken | Enzyme-linked immunosorbent assay (ELISA): a practical tool for rapid diagnosis of viruses and other infectious agents | |
| WO2002039114A3 (en) | Improved assay and reagents or immunological determination of analyte concentration | |
| Cho et al. | An enzyme immunoanalytical system based on sequential cross-flow chromatography | |
| EP0207152A1 (en) | DIFFUSION ANALYSIS IN A SOLID PHASE. | |
| Rennard et al. | Enzyme linked immunoassay (ELISA) for connective tissue proteins: type I collagen | |
| FR2662804B1 (fr) | Anticorps polyclonaux anti-lh et leurs applications a la detection et/ou au dosage de la lh, chez de multiples especes animales. | |
| Shamsuddin et al. | Improved enzyme immunoassays using biotin-avidin-enzyme complex | |
| Persson et al. | Enzyme-linked immunosorbent assay for subclass distribution of human IgG and IgA antigen-specific antibodies | |
| TR200100643T2 (tr) | Yüksek-çekimli antikorlar | |
| Linpisarn et al. | Sensitive sandwich enzyme immunoassay for serum ferritin on microtitre plates | |
| ATE320604T1 (de) | Homogene nachweisverfahren zur bestimmung von subpopulationen eines analyten | |
| KR960014336A (ko) | 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법 | |
| DE60235011D1 (de) | Assays für den präimplantationsfaktor und präimplantationsfaktorpeptide | |
| Derer et al. | Application of the dot immunobinding assay to allergy diagnosis | |
| DK199783A (da) | Immunoglobulin-halvmolekyler og fremgangsmaade til fremstilling af hybrid-antistoffer | |
| EP0166583A3 (en) | Compositions for enzyme immunoassay of prostaglandins | |
| Tew et al. | A radioimmunoassay for human antibody specific for microbial antigens | |
| CA2434694A1 (en) | Detection and quantification of cripto-1 | |
| ATE180894T1 (de) | Verwendung von polyklonalen humanen anti-htg- autoantikörpern als reagenz für die klinische diagnostik von schilddrüsen-autoimmunerkrankungen sowie reagenziensatz für eine bestimmung von anti-htg-autoantikörpern in patientenseren | |
| NO954979L (no) | Fremgangsmåte til sandwich immunoassay for N-peptid | |
| ES2076221T3 (es) | Derivados geminales de difenilo y su uso en inmunoensayos. | |
| KR850008620A (ko) | Atl 바이러스 항체의 측정방법 및 시약 | |
| DE60027176D1 (de) | Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1 | |
| CN219799468U (zh) | 一种侧向层析试纸条、检测试剂卡及检测试剂盒 | |
| ES2153066T3 (es) | Antigeno para inmunoensayo enzimatico y metodo para medir anticuerpos de eritrocito. |